Unborn baby, down syndrome, amniocentesis, rather than whether, by doing just a simple blood analysis of the DNA analysis that detects the first commercial test, at the end of this year, America is all about.

Introduction of targeted testing starting next year in Turkey, the United States more than 50 patents, and the human genome project initiation and execution that leads Boston University Advanced Biotechnology Center Director, Professor. Dr. Charles Cantor and his team developed as a result of a 10-year survey.
Exciting world of science test, 8 of pregnancy In April, it is a simple blood sample taken from the mother and gives results within two weeks.

Science Festival, a new method,''organized by the Institute of Informatics Informatics Professor of Turkish researchers recognized. Dr. Cantor, the diagnostic method is said to offer almost a near-perfect reliability.

Blood sample was taken for the implementation of the test within 72 hours from the mother reach the center that tells the Cantor,''At first you're going to ask the frozen state plasma. However, in the future when we receive blood samples stored at room temperature for 72 hours even in the narthex in the diagnosis,''he said.

These test''revolution''in the scientific world as Cantor described their voicing,''First of all, the results of a large application, so prevalent in society is expected to present results,''he said excitedly.